Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

This is the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

Guidehouse, a global consultancy providing advisory, digital, and managed services to the commercial and public sectors, has teamed up with the Healthcare Information and Management Systems Society ...

HIMSS digital maturity models have been used ... Guidehouse partner and Payer/Provider practice leader. "These models will help our clients assess their digital maturity, pinpoint opportunities ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

WOBURN, MA, UNITED STATES, February 12, 2025 /EINPresswire / -- ScribeEMR, a leading provider of AI-powered healthcare documentation solution ...